Oct 28, 2016 7:30am EDT Rigel Announces Conference Call and Webcast to Report Third Quarter 2016 Financial Results
Oct 20, 2016 7:00am EDT Rigel Announces Results from the Second FIT Phase 3 Study and the Long-Term Open-Label Extension Study for Fostamatinib in ITP
Oct 10, 2016 10:00pm EDT Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Aug 29, 2016 5:34pm EDT Rigel Announces Press Release and Conference Call Schedule on Tuesday, August 30, 2016
Aug 02, 2016 4:10pm EDT Rigel Announces Second Quarter 2016 Financial Results and Provides Portfolio Update
Jul 26, 2016 7:30am EDT Rigel Announces Conference Call and Webcast to Report Second Quarter 2016 Financial Results
